Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adding prednisolone to standard immunoglobulin therapy is beneficial for patients with severe Kawasaki disease.

Adding prednisolone to standard immunoglobulin therapy is beneficial for patients with severe Kawasaki disease. J Pediatr. 2012 Nov; 161(5):967.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.